Report overview
Cancer Janus Kinase Inhibitors
This report contains market size and forecasts of Cancer Janus Kinase Inhibitors in global, including the following market information:
Global Cancer Janus Kinase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Janus Kinase Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Janus Kinase Inhibitors companies in 2021 (%)
The global Cancer Janus Kinase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ruxolitinib Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Janus Kinase Inhibitors include Abbott Laboratories, Asana Biosciences, Astra Zeneca, Celon Pharmaceuticals, Dynamic Pharma, Eli Lilly, Gilead Sciences, Hanmi Pharmaceuticals and Incyte, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Janus Kinase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Janus Kinase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Janus Kinase Inhibitors Market Segment Percentages, by Type, 2021 (%)
Ruxolitinib
Momelotinib
Lestaurtinib
Pacritinib
Global Cancer Janus Kinase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Janus Kinase Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Cancer Janus Kinase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Janus Kinase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Janus Kinase Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Janus Kinase Inhibitors revenues share in global market, 2021 (%)
Key companies Cancer Janus Kinase Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Janus Kinase Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Asana Biosciences
Astra Zeneca
Celon Pharmaceuticals
Dynamic Pharma
Eli Lilly
Gilead Sciences
Hanmi Pharmaceuticals
Incyte
Kyowa Hakko
Moleculin
Pfizer
PIQUR Therapeutics
Portola Pharmaceuticals
S-BIO
